In a key post-recall milestone, Philips says it has more than doubled its number of 510(k) clearances from the U.S. Food and Drug Administration (FDA) over the past two years.
PLEASANTON, Calif., Jan. 29, 2024 (GLOBE NEWSWIRE) -- ProSomnus, Inc. (NASDAQ: OSA) (the “Company”), the leading non-CPAP Obstructive Sleep Apnea (OSA) therapy™, announced that the company is ...
PITTSBURGH — A Pennsylvania federal court remanded a California woman’s negligence complaint over injuries allegedly caused by a recalled Philips CPAP device back to Los Angeles County Superior Court.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results